Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Artera AIartera.aiArteraAI is a precision oncology company that uses a multi-modal AI platform to analyze digital pathology and clinical data for personalized cancer management. Its ArteraAI Prostate Test, the first AI test recommended in NCCN guidelines, predicts which intermediate-risk prostate cancer patients will benefit from short-term androgen deprivation therapy with radiation.
Sources
gethealthie.com shapes more of what AI says about Artera AI than any other source, at 33% of its citations.
itnonline.com · jpatholtm.org
The market map
Healthcare AI Triage and Imaging Software →Where AI ranks Artera AI
